Inflammatory Breast Cancer

Article Properties
Cite
Chevallier, Bernard, et al. “Inflammatory Breast Cancer”. American Journal of Clinical Oncology, vol. 16, no. 3, 1993, pp. 223-8, https://doi.org/10.1097/00000421-199306000-00006.
Chevallier, B., Roche, H., Olivier, J. P., Chollet, P., & Hurteloup, P. (1993). Inflammatory Breast Cancer. American Journal of Clinical Oncology, 16(3), 223-228. https://doi.org/10.1097/00000421-199306000-00006
Chevallier B, Roche H, Olivier JP, Chollet P, Hurteloup P. Inflammatory Breast Cancer. American Journal of Clinical Oncology. 1993;16(3):223-8.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
You May Also Like
Citations
Title Journal Journal Categories Citations Publication Date
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial

 Breast Cancer Research and Treatment
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 2024
Tailoring Treatment for Patients with Inflammatory Breast Cancer Current Treatment Options in Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 7 2023
Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer

 Scientific Reports
  • Medicine
  • Science
  • Science: Science (General)
 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

 Journal of Clinical Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 1 2023
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) Clinical and Translational Radiation Oncology 4 2022
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)163
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens147
Medicine: Pathology15
Medicine: Gynecology and obstetrics14
Medicine: Medicine (General): Medical technology13
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine13
Science: Biology (General)8
Medicine: Therapeutics. Pharmacology7
Medicine: Public aspects of medicine: Toxicology. Poisons7
Science: Biology (General): Cytology6
Medicine: Surgery6
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs5
Science: Chemistry: Organic chemistry: Biochemistry4
Medicine: Public aspects of medicine3
Medicine3
Science: Biology (General): Genetics3
Science2
Science: Science (General)2
Medicine: Internal medicine2
Medicine: Internal medicine: Special situations and conditions: Industrial medicine. Industrial hygiene1
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy1
Science: Physics1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system1
The category Medicine: Medicine (General) 163 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Management of locally advanced carcinoma of the breast: II. Inflammatory carcinoma and was published in 1994. The most recent citation comes from a 2024 study titled Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial. This article reached its peak citation in 2006, with 17 citations. It has been cited in 99 different journals, 14% of which are open access. Among related journals, the Annals of Oncology cited this research the most, with 14 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year